Brought to US Healthcare professionals by Acorda Therapeutics
Dr. Ray Dorsey, the David M. Levy Professor of Neurology and Director of the Center for Health + Technology at the University of Rochester Medical Center, discusses the use of telemedicine in managing Parkinson’s disease. Dr. Dorsey discusses his own approach to telemedicine, the advantages and disadvantages of telemedicine in a neurology clinic, and the utility of telemedicine post COVID-19.
Dorsey ER, et al. J Parkinsons Dis. 2020; 10(3):893-897., Parkinson J. 1817. J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36., U.S. Census Bureau Quickfacts.
https://www.census.gov/quickfacts/fact/table/US/PST045219. Accessed March 22, 2021., Verma S. “Early Impact Of CMS Expansion Of Medicare Telehealth During COVID-19: Health Affairs Blog.” Health Affairs, 15 July 2020,
www.healthaffairs.org/do/10.1377/hblog20200715.454789/full/., Willis AW, et al. Neurology. 2011 Aug 30; 77(9), 851-7.